FA 2015 Flashcards
describe de novo synthesis of pyrimidines
make temporary base - orotic acid
add sugar and phosphate
modify base
whats used to make pyrimidines
carbamoyl phosphate + aspartate
describe de novo synthesis of purines
start with sugar and phosphate
add base
whats used to make purines
2x N10 formyl tetrahydroholate glycine glutamine aspartate CO2
leflunomide
carbamoyl phosphate –> X inhibits dihydroorate dehydrogenase X –> orotic acid
orotic aciduria
inhibits enzyme involved in conversion of orotic acid to UMP
hydroxyurea
UDP –> X inhibits ribonucleotide reductase X –> dUMP
5-flurouracil
dUMP –> X inhibits thymydilate synthase –> dTMP
decreased dTMP
methotrexate
trimethoprim
pyrimethamine
humans
bacteria
protozoa
DHF –> X inhibits dihydrofolate reductase X –> THF
6- MP
azithropurine
inhibites de novo purine synthesis
mycophenylate
ribavirin
IMP –> X IMP dehydrogenase X –> GMP
allopurinol
febuxostat
salvage purine pathway
hypoxanthine –> X inhibits xanthine oxidsase X –> xanthine –> X inhibits xanthine oxidase X –> uric acid
probenecid
uric acid –> INHIBITS –> urine
UGG
tryptophan - ony one codon = exception to degenerate/redundancy of the genetic code
AUG
methionine - only one codon = exception to degenerate/redundancy of the genetic code
describe DNA polymerase III
prokaryotic only
5’-3’ synthesis
3’-5’ exonuclease activity for proofreading
describe DNA polymerase I
prokaryotic only
5’-3’ synthesis to replace RNA primer with DNA
3-5’ exonuclease
5’-3’ exonuclease to get rid of RNA primer
Xeroderma pigmentosum - what goes wrong
defective ssDNA repair by UV light corrected by nucleotide excision (oligonucleotide removal, occurs in G1) – can’t fix pyrimidine dimers due to UV
HNPCC - what goes wrong
defective ssDNA repair by mismatch - errors that occur in synthesis that are corrected in G2
Ataxia telangiectasia and Fanconi Anaemia - what goes wrong
defective dsDNA repair by nonhomolougous end joining - correction of double stranded breaks (may lose genetic material, don’t need to be homologous)
Xermoderma pigmentosum - clinical presentation
predisposition to squamous cell carcinoma + basal cell carcinoma + malignant melanoma at an early age due to inability to repair pyridine dimers produced by exposure to UV light (nucleotide excision)
AR
numerous hyperpigmented lesions and nodular and scaly growthrs on face
goljan page 206 for pic
HNPCC - clinical presentation
increased risk of colorectal cancers without previous polyps; caused by germ line mutation in mismatch repair genes/G2 that cause a microsatellite repeat replication error/microsatellite instability – predispose to replication errors if there are mtuations in DNA repair enzymes/MMR genes – microsatellites become unstable (become longer or shorter) and produce RAMESHIFT mutatiosn that in activate or alter tumor suppressore gene function leading to cancer. MSI found in majority of HPMCC patients. :) try to not copy exact nedxt time becky :) its okay today bc you are a pukey face.
Ataxia telangiectasia - clinical presentation
increased risk of developing malignant lymphomas
Fanconi Anaemia - clinical presentation
can cause aplastic anaemia
don’t mess up with fanconi syndrome: polyuria, renal tubular acidosis type II, growth failure, electrolyte imbalances, hypophosphatemic rickets
what is fMet
AUG in bacteria - start codon
AND
stimulates neutrophil chemotaxis
list the stop codons pleease
journing of December till now
You go away UGA
You are away UAA
You are gone UAG
amantia phalloides!!!
inhibits RNA polymerase II - makes mRNA and can open NDA at promoter site
CXPX: four phases – asymptomatic – gi with diarrhoea and vomiting severe – apparent recovery – renal and liver failure in 7-10 days BCHM NOTES THROWBACK
rifampin
inhibits RNA polymerase in prokaryotes
Actinomycin D
inhibits RNA polymerase in prokaryotes and eukaryotes
whats the polyadenylation signal?
AAUAAA!!
sequence in the intron that splicesome makes a lariate out of
exon2 - OH - P - GU- A- AG - P - exon1
anti-spliceosomal snRNPs/antismith abs
highly sensitive (rule out bc TN high) SLE
anti-U1 RNP abs
highly associated with MCTD - mixed connective tissue disease
Define and give examples of permanent cells
remain in G0 + regenerate from stem cells
ex: neurons, skeletal muscle, cardiac muscle, red blood cells
Define and give examples of stable/quiescent cells
enter G1 from G0 when stimulated
ex: hepatocytes and leukocytes
Define and give examples of labile cells
nover go to Go, divide rapidly with a short Gi, most susceptible to chemotherapy
ex: bone marrow, gut epilthelium, skin, hair follicle, germ cells
Role of the Golgi
distribution centre for proteins and lipids from the ER to vesicles/plasma membrane or lysosome
N-oligosaccaharides are modified at ASPARAGINE
O-oligosaccharides are added to LYSINE and SERINE
addition of mannose-6-phosphate sends to lysosome for destruction
I cell disease pathophys
N-acetylglucosaminyl-1-phosphotransferase –> failure to phosphorylate mannose residues on glycoproteins in the Golgi –> are secreted extracellulary instead of trafficked to vesicles,
I cell disease cxpx
coarse facial features clouded corneas restricted joint movement high plasma level of lysosomal enzymes often fatal in childhood